2023-01-24 23:46:00

EQUITY ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Bioventus Inc. Investors with Losse

Logo Benzinga
Benzinga
By Business Wire

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the stock of Bioventus Inc. BVS: (i) pursuant and/or traceable to the offering documents issued in connection with the Company's February 11, 2021 initial public offering (the "IPO" or "Offering"); and/or (ii) between February 11, 2021 and November 21, 2022, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than March 13, 2023.

SO WHAT: If you purchased Bioventus securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Bioventus class action, go to https://rosenlegal.com/submit-form/?case_id=10065 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 13, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Continue read on benzinga.com

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 02:00:00
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Bioventus...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-23 21:52:00
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of North Carolina...

Logo PR Newswire
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-19 20:04:00
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Bioventus Inc. ("Bioventus" or...

Logo PR Newswire
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of International...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 15:19:00
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of RYVYL Inc....

Logo PR Newswire
NEW YORK, Jan. 19, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bioventus Inc. ("Bioventus" or the...

Logo PR Newswire
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Twist...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 06:45:00
Did you lose money on investments in Veru? If so, please visit Veru Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 06:45:00
Did you lose money on investments in NeoGenomics, Inc.? If so, please visit NeoGenomics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at...

Logo PR Newswire
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Enovix...

Logo PR Newswire
MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer...

Logo GlobeNewswire
SciencePress Release2023-01-24 21:01:00
CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers...

Logo GlobeNewswire
SciencePress Release2023-01-24 12:00:00
EMERYVILLE, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the...

Logo Kitco NEWS
EconomyBy Ernest Hoffman2023-01-24 15:19:53
Editor's Note: With so much market volatility, stay on top of daily news! Get caught up in minutes with our speedy summary of today's must-read news and...

Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...

Logo PR Newswire
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Y-mAbs...

Logo PR Newswire
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of International...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 14:01:00
Robbins Geller Rudman & Dowd LLP announces that purchasers of Y-mAbs Therapeutics, Inc. YMAB common stock on the open market, or pursuant to Registration...

Logo PR Newswire
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on...